Cita APA

Bordet, S., Grasso, L., Udovin, L., Chevalier, G., Otero-Losada, M., Capani, F., & Pérez-Lloret, S. (2025). An open‐label, non‐randomized, drug‐repurposing study to explore the clinical effects of Angiotensin II Type 1 (AT1) receptor antagonists on anxiety and depression in Parkinson's Disease. Web

Citación estilo Chicago

Bordet, Sofía, Lina Grasso, Lucas Udovin, Guenson Chevalier, Matilde Otero-Losada, Francisco Capani, and Santiago Pérez-Lloret. An Open‐label, Non‐randomized, Drug‐repurposing Study to Explore the Clinical Effects of Angiotensin II Type 1 (AT1) Receptor Antagonists On Anxiety and Depression in Parkinson's Disease. 2025.

Cita MLA

Bordet, Sofía, et al. An Open‐label, Non‐randomized, Drug‐repurposing Study to Explore the Clinical Effects of Angiotensin II Type 1 (AT1) Receptor Antagonists On Anxiety and Depression in Parkinson's Disease. 2025.